Cell Surface Markers Market

Cell Surface Markers Market, By Product Type (Flow Cytometers, Hematology Analyzers, Reagents and Kits), By Application (Disease Diagnosis and identification, Research/Drug Discovery), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Cell surface markers are special proteins expressed on the surface of cells or carbohydrates attached to the cell membrane that often conveniently serve as markers of specific cell types. While some proteins have the task of allowing the transport of molecules across the membrane, cell surface markers play a role in inter-cellular communication and recognition. Cell surface markers are used to classify cells according to its markers. This data, in turn, is used to identify different kinds of cells, from cancer cells to stem cells to cells infected with HIV. In short, cell surface markers are like a fingerprint, specific to each kind of cell, and capable of being identified according to what kinds of markers are present on the membrane. Currently, the most common cell surface markers are CD antigen, also known as CD molecules and clusters of differentiation. While CD molecules are very useful in defining leukocytes, they are not merely markers on the cell surface. While only a fraction of known CD molecules have been thoroughly characterized, most of them have an important function. Beyond the mere identification of cells, cell surface markers also hold the potential to aid in drug discovery and especially personalized medicine. With the ability to identify individual cells according to surface markers, scientists are beginning to make breakthroughs in the development of new drugs.

Market Dynamics

Increasing launches of new products, and mergers and acquisitions by key market players is expected to drive the global cell surface markers market growth. For instance, on January 13, 2021, Becton, Dickinson and Company, a U.S. based multinational medical technology company announced the commercial release of the BD AbSeq Immune Discovery Panel (IDP), a state-of-the-art, pre-titrated antibody-oligo based discovery tool designed to investigate 30 immune markers in a single experiment. The BD AbSeq IDP builds upon the advances of the BD AbSeq Assay, which analyzes protein expression at the single-cell level using next-generation sequencing. The BD AbSeq IDP offers researchers convenience, reliability and flexibility as both a multiomics-enabled and cost-efficient tool to aid in immune research and discovery. Also built upon BD antibody-oligo based technology, the BD AbSeq IDP consists of 30 different specificities targeting most major immune markers, conveniently grouped together in a single tube. The panel helps enable immune cell type identification.

Key features of the study:

• This report provides an in-depth analysis of the global cell surface markers market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cell surface markers market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Sysmex Corporation, and Thermo Fisher Scientific, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global cell surface markers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell surface markers market

Detailed Segmentation:

• Global Cell Surface Markers Market, By Product Type:
• Flow Cytometers
• Hematology Analyzers
• Reagents and Kits
• Global Cell Surface Markers Market, By Application:
• Disease Diagnosis and identification
• Research/Drug Discovery
• Global Cell Surface Markers Market, By Region:
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East:
• GCC
• Israel
• Rest of Middle East
• Africa
• Central Africa
• South Africa
• North Africa
• Company Profiles
• Abbott Laboratories, Inc.
• Beckman Coulter, Inc.
• BD Biosciences
• Bio-Rad Laboratories, Inc.
• Grifols SA
• Immucor, Inc.
• Janssen Diagnostics, Inc.
• Nihon Kohden Corporation
• F. Hoffmann-La Roche Ltd.
• Siemens Healthcare
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.